Funding for this research was provided by:
Eisai Incorporated (N/A)
Received: 9 October 2020
Accepted: 17 February 2021
First Online: 18 March 2021
Ethics approval and consent to participate
: All procedures performed in the source studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All patients provided written informed consent.
: Not applicable (no individual patient data are published in this article).
: IR Macpherson has participated in advisory boards for Celldex Therapeutics, Daiichi-Sankyo, Eisai, Genomic Health, Novartis, Roche, and Pfizer.Y He is a former employee of Eisai Inc.C Palmieri has received funding from AstraZeneca, Pfizer, and Genomic Health, and has participated in advisory boards for Daiichi-Sankyo, Eisai, Genomic Health, Pfizer, Novartis, and Roche.